Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Inovio Pharmaceuticals IncTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 1044.7× Inovio Pharmaceuticals Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

INOREGN
Market Cap
$78.55M$82.06B
Sector
HealthHealth
52-Week High
$2.87$812.27
52-Week Low
$0.66$555.51
Enterprise Value
$49.56M$76.77B
Dividend Yield
0.47%

Returns comparison

Trailing returns across standard periods

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN